Inpharmsp. z o.o. + limited partnership
Agents specialised in the sale of other particular products
Overview
Inpharm has supplied original medicines through parallel imports since 2006 and produces 1.5 million packs monthly; its products reach nearly all pharmacies in Poland. Under the Nexon Pharma brand, the company manufactures and distributes dietary supplements, medical devices and cosmetics.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 40 days early. 2 of 6 audited by a statutory auditor.
- 202523/06/2026
- 202427/06/2025
- 202321/06/2024
- 202228/06/2023
- 202113/07/2022
- 202014/05/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
- Advertising (73.1)
Public procurement
Inpharm is the contractor in one public sector contract, worth USD 972.45.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Aug 14, 2026 | Supply of medicines for chemotherapy | $972.45 | 5 Wojskowy Szpital Kliniczny z Polikliniką-Samodzielny Publiczny Zakład Opieki Zdrowotnej w Krakowie |
Partners
| Partners |
|---|
Sławomir Radosław Bernaciakage 55 |
Marzena Teresa Idzikowskaage 56 |
Inpharm Sp. z o.o. |
Agata Matylda Zalega Bernaciakage 53 |
Manner of representation
The general partner is entitled to represent the company independently. The management board of the general partner – INPHARM sp. z o.o. – comprises: 1. Sławomir Bernaciak – President of the Management Board; 2. Marzena Idzikowska – member of the management board; 3. Agata Zalega-Bernaciak – member of the management board. Each member of the management board of the general partner – INPHARM sp. z o.o. – is entitled to represent it independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2011-01-03.
62 1050 1025 1000 0025 0621 8334- 66 1050 1025 1000 0025 0621 8359
- 84 1050 1025 1000 0025 0621 8326
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 22, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $15,068$15,068 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Qpharmasp. z o.o. | $16,010,159.04 | qpharma.pl | ||
| PolypharmS.A. | $13,660,727.48 | polypharm.pl | ||
| Nutropharmasp. z o.o. | $13,240,122.91 | nutropharma.pl | ||
| Interpharmasp. z o.o. | $12,321,125.25 | interpharma.com.pl | ||
| POL-NILsp. z o.o. | $9,170,055.52 | pol-nil.com.pl | ||
| Wellmedica Hfsp. z o.o. | $8,037,044.71 | wellmedica.pl | ||
| Simply You Polandsp. z o.o. | $7,463,283.82 | simply-you.pl | ||
| Pharm Supplysp. z o.o. | $6,901,751.00 | pharmsupply.com.pl | ||
| Nutramaticsp. z o.o. | $6,205,312.16 | nutramatic.pl | ||
| Bestpharmasp. z o.o. | $5,786,190.68 | bestpharma.pl |
FAQ
Last updated: 2026-06-23